2-(2-methylcyclopropyl)acetic acid | 139492-14-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-(2-methylcyclopropyl)acetic acid
• CAS: 139492-14-1
• 化学式: C₆H₁₀O₂
• mdl: MFCD19229078
• 分子量: 114.144
• InChiKey: MKWZWXDSHKBYAO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  8
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.833
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(2-methylcyclopropyl)acetic acid 、 二甲羟胺盐酸盐 在 N,N'-羰基二咪唑 作用下， 以 二氯甲烷 为溶剂， 生成 N-methoxy-N-methyl-2-(2-methylcyclopropyl)acetamide
  参考文献：
  名称：

  PYRIDINE N-OXIDE DERIVATIVES USEFUL AS FACTOR XIA INHIBITORS

  摘要：

  The present invention is directed to pyridine N-oxide derivatives, stereoisomers, isotopologues, isotopomers and pharmaceutically acceptable salts thereof, pharmaceutical compositions containing said compounds and the use of said compounds in the treatment and/or prophylaxis of thromboembolic disorders, inflammatory disorders and diseases or conditions in which plasma kallikrein activity is implicated.

  公开号：

  US20230091768A1
• 作为产物：
  描述：

  β-isopropenyl-β-propiolactone 在 9-borabicyclo[3.3.1]nonane dimer 、 sodium methylate 作用下， 生成 2-(2-methylcyclopropyl)acetic acid
  参考文献：
  名称：

  TRANSFORMATION OF β-ALKENYL-β-PROPIOLACTONES INTO CYCLOPROPYLACETIC ACIDS UTILIZING HYDROBORATION

  摘要：

  β-烯烃-β-丙烯内酯与9-硼双环[3.3.1]双烯的反应以及后续用甲氧基钠处理，生成了良好产率的环丙基乙酸。

  DOI：

  10.1246/cl.1983.1273

文献信息

• [EN] ETHER COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS<br/>[FR] COMPOSÉS ÉTHER POUR LE TRAITEMENT DE TROUBLES MÉDICAUX
  申请人：ACHILLION PHARMACEUTICALS INC

  公开号：WO2017035355A1

  公开（公告）日：2017-03-02

  Compounds, methods of use, and processes for making inhibitors of complement Factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof wherein R12 or R13 on the A group is an ether substituent (R32) are provided. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduce the excessive activation of complement.

  提供了一种包括化合物、使用方法和制备过程的抑制补体因子D的方法，其中所述方法包括化合物I的结构，或其药用盐或组合物，其中A组上的R12或R13是醚取代基（R32）。本文描述的抑制剂靶向因子D并抑制或调节补体级联反应。本文描述的因子D抑制剂减少了补体的过度激活。
• EFTU INHIBITORS OR AMINOTHIAZOLES AND THEIR USES
  申请人：LaMarche Matthew J.

  公开号：US20080221142A1

  公开（公告）日：2008-09-11

  The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of diseases.

  本申请描述了对治疗、预防和/或改善疾病有用的有机化合物。
• AMINOTHIAZOLES AND THEIR USES
  申请人：Bushell Simon

  公开号：US20140315790A1

  公开（公告）日：2014-10-23

  The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of diseases.

  本申请描述了对治疗、预防和/或改善疾病有用的有机化合物。
• Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same
  申请人：Hoveyda Hamid R.

  公开号：US20110105389A1

  公开（公告）日：2011-05-05

  The present invention provides novel conformationally-defined macrocyclic compounds that have been demonstrated to be selective modulators of the ghrelin receptor (GRLN, growth hormone secretagogue receptor, GHS-R1a and subtypes, isoforms and/or variants thereof). Methods of synthesizing the novel compounds are also described herein. These compounds are useful as antagonists or inverse agonists of the ghrelin receptor and as medicaments for treatment and prevention of a range of medical conditions including, but not limited to, metabolic and/or endocrine disorders, obesity and obesity-associated disorders, appetite or eating disorders, addictive disorders, cardiovascular disorders, gastrointestinal disorders, genetic disorders, hyperproliferative disorders, central nervous system disorders and inflammatory disorders.

  本发明提供了新型构象定义的大环化合物，已被证明是生长激素分泌素受体（GRLN，生长激素分泌素受体，GHS-R1a及其亚型、异构体和/或变种）的选择性调节剂。本文还描述了合成这些新型化合物的方法。这些化合物可用作生长激素分泌素受体的拮抗剂或逆向激动剂，以及用于治疗和预防一系列医学疾病，包括但不限于代谢和/或内分泌紊乱、肥胖和与肥胖相关的疾病、食欲或进食紊乱、成瘾紊乱、心血管疾病、胃肠道疾病、遗传疾病、过度增殖性疾病、中枢神经系统疾病和炎症性疾病。
• Inhibition of nematode induced root damage by derivatives of methylenecyclopropane acetic acid
  作者：James T. Pechacek、Thomas M. Bargar、Mark R. Sabol

  DOI：10.1016/s0960-894x(97)10045-2

  日期：1997.10

  Methylenecyclopropane acetic acid (MCPA), an inhibitor of fatty acid oxidation, and several derivatives were shown to be potent inhibitors of root galling induced by the nematode pest Meloidogyne incognita. (C) 1997 Elsevier Science Ltd.